Effectiveness and Safety of Once-Weekly Semaglutide 2.4 mg in Korean Adults With Obesity or Overweight: A Multicenter Retrospective Real-World Study (RE-SEMA-K Study)

Diabetes/metabolism research and reviews · 2026 Nov · Kwon YJ, Kim YS, Ko HJ et

By Maren Holt · Senior Reporter, GLP-1

Oct 31 20:00 ETSource: Diabetes/metabolism research and reviews

From the source

Effectiveness and Safety of Once-Weekly Semaglutide 2.4 mg in Korean Adults With Obesity or Overweight: A Multicenter Retrospective Real-World Study (RE-SEMA-K Study)
Diabetes/metabolism research and reviews · 2026 Nov · Kwon YJ, Kim YS, Ko HJ et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/43001810/